Pulmonx Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 17.19 million compared to USD 13.95 million a year ago. Net loss was USD 16.2 million compared to USD 14.64 million a year ago. Basic loss per share from continuing operations was USD 0.43 compared to USD 0.4 a year ago.
For the six months, sales was USD 31.73 million compared to USD 24.74 million a year ago. Net loss was USD 32.06 million compared to USD 30.47 million a year ago. Basic loss per share from continuing operations was USD 0.85 compared to USD 0.83 a year ago.